Evaluating management of progressive disease for control arm patients in trials of first line PD-1 or PD-L1 inhibitor-based treatment for metastatic solid tumours

Maniar, A., Haslam, A., & Prasad, V. (2022). Evaluating management of progressive disease for control arm patients in trials of first line PD-1 or PD-L1 inhibitor-based treatment for metastatic solid tumours. European Journal of Cancer, 164, 95–104. https://doi.org/10.1016/j.ejca.2022.01.006
Authors:
Ashray Maniar
Alyson Haslam
Vinay Prasad
Affiliated Authors:
Ashray Maniar
Columbia Affiliation:
Subjects:
Neoplasms (MeSH)
Programmed Cell Death 1 Receptor (MeSH)
Author Keywords:
clinical trial design
immunotherapy
checkpoint inhibitor
oncology
elink
Publication Type:
Article
Unique ID:
10.1016/j.ejca.2022.01.006
PMID:
35182927
DOI:
10.1016/j.ejca.2022.01.006
Journal:
European Journal of Cancer
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created: